首页> 外文期刊>World Journal of Gastroenterology >Preoperative risk factor analysis in orthotopic liver transplantation with pretransplant artificial liver support therapy.
【24h】

Preoperative risk factor analysis in orthotopic liver transplantation with pretransplant artificial liver support therapy.

机译:移植前人工肝支持治疗原位肝移植术前危险因素分析。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To assess the value of pre-transplant artificial liver support in reducing the pre-operative risk factors relating to early mortality after orthotopic liver transplantation (OLT). METHODS: Fifty adult patients with various stages and various etiologies undergoing OLT procedures were treated with molecular adsorbent recycling system (MARS) as preoperative liver support therapy. The study included two parts, the first one is to evaluate the medical effectiveness of single MARS treatment with some clinical and laboratory parameters, which were supposed to be the therapeutical pre-transplant risk factors, the second part is to study the patients undergoing OLT using the regression analysis on preoperative risk factors relating to early mortality (30 d) after OLT. RESULTS: In the 50 patients, the statistically significant improvement in the biochemical parameters was observed (pre-treatment and post-treatment). Eight patients avoided the scheduled Ltx due to significant relief of clinical condition or recovery of failing liver function, 8 patients died, 34 patients were successfully bridged to Ltx, the immediate outcome of this 34 patients within 30 d observation was: 28 kept alive and 6 patients died. CONCLUSION: Pre-operative SOFA, level of creatinine, INR, TNF-alpha, IL-10 are the main preoperative risk factors that cause early death after operation, MARS treatment before transplantation can relieve these factors significantly.
机译:目的:评估移植前人工肝支持在降低与原位肝移植(OLT)后早期死亡相关的术前危险因素中的价值。方法:采用分子吸附循环系统(MARS)作为术前肝支持治疗方法,对五十名经历不同分期和病因的成人患者进行了OLT手术。该研究包括两部分,第一部分是通过一些临床和实验室参数来评估单一MARS治疗的医学有效性,这些参数被认为是治疗前的移植危险因素;第二部分是使用以下方法研究接受OLT治疗的患者OLT术后早期死亡(30 d)相关的术前危险因素的回归分析。结果:在50名患者中,观察到生化参数的统计学显着改善(治疗前和治疗后)。由于临床状况的明显缓解或肝功能衰竭的恢复,有8例患者避免了预定的Ltx,8例患者死亡,34例成功桥接至Ltx,这34例患者在30天内观察到的直接结果是:28例存活,6例患者死亡。结论:术前SOFA,肌酐,INR,TNF-α,IL-10水平是导致术后早期死亡的主要术前危险因素,移植前进行MARS治疗可明显缓解这些因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号